Dietary Supplement Formulation Development and Scale-Up
Vici manufactures custom dietary supplements. Clients generally begin in one of two places: they have a complete quantitative formula ready for manufacturing review, or they have selected the active ingredients and target amounts per serving but need Vici to develop the finished formulation.
Vici is not a white-label company and does not offer a catalog of stock formulas for relabeling. Each product is based on a client-provided formula or a custom formula developed for that client, then supported through sourcing, cGMP release, pilot manufacturing, testing, packaging, and scale-up.
Start With the Active Ingredients and Required Dose
Development begins by defining each active ingredient and its target amount per serving. Vici also confirms the intended dosage form, serving count, consumer-use requirements, sensory expectations, label constraints, package, shelf-life objective, cost target, and anticipated manufacturing volume.
These decisions must work together. A high active-ingredient load may not fit into one small tablet or two capsules. A botanical extract may create taste, flow, color, or stability challenges. The intended batch size can also affect equipment selection, mixing, transfer, compression, filling, and yield.
Ingredient Sourcing and cGMP Release Come First
Vici can source project-specific ingredients or evaluate suitable client-supplied materials. Ingredient source, grade, particle properties, potency, documentation, and consistency can materially affect formulation and manufacturing performance, so sourcing decisions should be made before development is finalized.
For cGMP manufacturing, materials must be received, documented, sampled, and released under the applicable quality procedures before use. The program may include supplier and certificate-of-analysis review, identity testing, and other specification-based testing appropriate to the ingredient and project.
Inactive Ingredients Make the Product Manufacturable
The active ingredients define what the supplement is intended to deliver. Inactive ingredients help turn those actives into a product that can be manufactured consistently, used as intended, and remain acceptable through shelf life.
- Fillers and binders provide appropriate size, structure, and tablet strength.
- Disintegrants help tablets break apart; glidants and lubricants support powder flow and equipment performance.
- Sweeteners, flavors, acidulants, and mouthfeel modifiers improve chewables, powders, and liquids.
- Suspending agents, viscosity modifiers, pH adjusters, and preservatives may be needed for liquid products.
The type and amount of each inactive ingredient are selected for the specific active ingredients, dosage form, manufacturing process, consumer experience, label requirements, and intended scale—not from a standard white-label formula.
Ready to Get Started?
Tell us about your upcoming project
A Rapid, Transparent Development Process
Vici uses focused iterations to resolve the highest-risk question first. Before each iteration, we share the proposed formula or experimental direction with the client so ingredient, labeling, commercial, and sensory constraints can be reviewed before work proceeds.
Prototype results guide the next round. A change that improves compression but creates a chalky chew, or a flavor system that improves taste but makes a blend sticky, is evaluated as one formulation-and-manufacturing problem rather than as separate decisions.
The Pilot Batch Is Both a Manufacturing and Marketing Step
A laboratory prototype shows that the formulation can work under limited conditions. A pilot batch tests whether the formula and process can work with representative equipment, mixing, transfer, hold times, environmental exposure, packaging, and expected yield.
When included in the project scope, the pilot can also serve as a marketing pilot by producing finished, packaged, and labeled product for initial market use or commercial evaluation. The batch may include an approved master manufacturing record, cGMP controls, in-process checks, quality-control release testing, packaging, labeling, and documented disposition.
Scale-Up and Repeat Manufacturing
Manufacturing performance can change with scale. Blender fill, mixing efficiency, shear, heat transfer, powder consolidation, liquid-addition rate, compression dwell, filling speed, process holds, and material transfer may behave differently as batch size increases.
Vici uses the development and pilot results to establish a practical process, batch documentation, in-process controls, specifications, testing requirements, raw-material needs, packaging approach, and scale-up plan for repeat manufacturing.
Frequently Asked Questions
Do I need to provide a finished formula?
No. You may provide a complete quantitative formula, or you may provide the active ingredients and target amounts per serving and engage Vici to develop the complete formulation. A finalized and approved formula is required before manufacturing begins.
Does Vici offer white-label or stock supplement formulas?
No. Vici is a custom development and manufacturing company, not a white-label supplier. We do not maintain a catalog of stock products for relabeling. Each product is manufactured from the client’s formula or from a formula Vici develops specifically for that client.
Can Vici manufacture a formula developed by another company?
Yes. Vici first performs a feasibility review of the formula, ingredients, documentation, process, specifications, packaging, and intended batch size. If changes are needed for reliable manufacturing, we explain them before proceeding.
Is an active-ingredient list enough to begin?
Yes, if it includes the target amount of each active ingredient per serving. Vici will also need the intended dosage form, serving size, sensory and label constraints, packaging concept, and anticipated volume. The active-ingredient list starts formulation development; it is not itself a manufacturing-ready formula.
Can Vici source the ingredients and packaging?
Yes. Vici can source project-specific materials or evaluate suitable client-supplied materials. All materials used in cGMP manufacturing must meet the agreed documentation, qualification, and release requirements before use.
What is the purpose of the pilot batch?
The pilot confirms the formulation and manufacturing process at a meaningful scale. When scoped appropriately, it can also generate tested, packaged, and labeled product for initial market use or commercial evaluation before a larger production commitment.
How many development iterations will be required?
That depends on the product and the remaining uncertainty. Vici scopes defined iterations around specific technical decisions. A straightforward capsule may need limited development, while a high-load chewable with taste and compression challenges may require up to four or sometimes more focused rounds. Vici can ship formulation development prototypes to the client for their evaluation and feedback.